The concept of a cure in oncology, particularly for stage II and III colon cancer (CC), has historically suffered from ...
The FDA has accepted for review Chiesi’s New Drug Application (NDA) for their investigational maintenance treatment for ...
A new report released by the WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) examines the global and ...
In a single-center retrospective observational study at the Bari Polyclinic, researchers analyzed 50 adults with non-segmental vitiligo affecting 0.5 to 10% of their body surface area, including the ...
An expert discusses how treatment decisions must balance short-term burden with long-term benefits while avoiding protocol-driven step therapy requirements, as future comparative effectiveness trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback